期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間： 較慢,6-12周

The Journal of Biopharmaceutical Statistics, a rapid publication journal, discusses quality applications of statistics in biopharmaceutical research and development. Now publishing six times per year, it includes expositions of statistical methodology with immediate applicability to biopharmaceutical research in the form of full-length and short manuscripts, review articles, selected/invited conference papers, short articles, and letters to the editor. Addressing timely and provocative topics important to the biostatistical profession, the journal covers:

Drug, device, and biological research and development;

Drug screening and drug design;

Assessment of pharmacological activity;

Pharmaceutical formulation and scale-up;

Preclinical safety assessment;

Bioavailability, bioequivalence, and pharmacokinetics;

Phase, I, II, and III clinical development including complex innovative designs;

Premarket approval assessment of clinical safety;

Postmarketing surveillance;

Big data and artificial intelligence and applications.

《生物制藥統(tǒng)計(jì)學(xué)雜志》是一本快速出版的雜志，探討統(tǒng)計(jì)學(xué)在生物制藥研究和開發(fā)中的高質(zhì)量應(yīng)用。該雜志目前每年出版六期，以全文和短篇手稿、評(píng)論文章、精選/受邀會(huì)議論文、短文和致編輯的信的形式闡述可直接應(yīng)用于生物制藥研究的統(tǒng)計(jì)方法。該期刊探討了對(duì)生物統(tǒng)計(jì)學(xué)專業(yè)來說重要的、及時(shí)且發(fā)人深省的話題，內(nèi)容涵蓋：

藥物、設(shè)備和生物研發(fā)；

藥物篩選和藥物設(shè)計(jì)；

藥理活性評(píng)估；

藥物配方和放大；

臨床前安全性評(píng)估；

生物利用度、生物等效性和藥代動(dòng)力學(xué)；

I、II 和 III 期臨床開發(fā)，包括復(fù)雜的創(chuàng)新設(shè)計(jì)；

上市前臨床安全性批準(zhǔn)評(píng)估；

上市后監(jiān)測(cè)；

大數(shù)據(jù)和人工智能及應(yīng)用。

《Journal Of Biopharmaceutical Statistics》(生物制藥統(tǒng)計(jì)雜志)編輯部通訊方式為TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106。如果您需要協(xié)助投稿或潤(rùn)稿服務(wù)，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對(duì)一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。